EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

When Glycaemic Control Comes Too Fast: Treatment‐Induced Neuropathy of Diabetes and Charcot Neuro‐Osteoarthropathy as Emerging Iatrogenic Complications of Rapid Metabolic Correction

Dured Dardari iD

Diabetes/Metabolism Research and Reviews · 2026-09 · 42 (6)

DOI: 10.1002/dmrr.70210 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 20.08.2026. Verfasst von Dured Dardari. Beteiligte Einrichtung: Diabetology Department, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Glycemic Control, Arthropathy, Neurogenic, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of Review Diabetes therapeutics can lower glycated haemoglobin (HbA1c) by several percentage points within weeks. While long‐term microvascular risk is reduced by improved glycaemia, abrupt metabolic transitions may destabilise tissues adapted to chronic hyperglycemia. We review treatment‐induced neuropathy of diabetes (TIND) and active Charcot neuro‐osteoarthropathy (CNO) as two neurovascular complications reported after rapid glycaemic correction, and we propose a unifying ‘metabolic tempo’ framework for prevention and early detection. Recent Findings TIND is an acute, painful small‐fibre and autonomic neuropathy occurring within 2–8 weeks after large HbA1c reductions, frequently coinciding with early worsening of retinopathy and nephropathy. Human in vivo nerve imaging demonstrates epineurial arteriovenous shunting and proliferative, leaky microvessels, supporting a microvascular dysregulation/ischaemia‐reperfusion model. For CNO, causal evidence linking rapid glycaemic improvement to disease onset remains limited and mainly observational; however, multiple case reports (including pregnancy, post‐transplantation, and major weight loss contexts) and retrospective cohorts suggest that major glycaemic ‘deceleration’ may cluster in the months preceding active CNO in susceptible patients with long‐standing neuropathy. Summary Rapid glycaemic correction should not be avoided when urgently needed, but ‘tempo‐aware’ strategies may be warranted in microvascularly fragile patients (very high baseline HbA1c, established neuropathy/retinopathy, kidney disease, or major weight loss). We outline pragmatic risk stratification, surveillance, and interdisciplinary pathways (neurology‐podiatry‐ophthalmology‐nephrology) to reduce delayed diagnosis and prevent deformity and disability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesGlycemic ControlArthropathy, NeurogenicHypoglycemic AgentsIatrogenic DiseaseDiabetes Mellitus, Type 2HumansGlycated Hemoglobin

Stichwörter der Autor:innen

Charcot neuro‐osteoarthropathyearly worseninginsulin neuritismetabolic tempomicrovascular complicationsrapid glycaemic correctiontreatment‐induced neuropathy of diabetes

Substanzen

Hypoglycemic AgentsGlycated Hemoglobin

Autor:innen und Institutionen

  • Diabetology Department, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France.
  • Laboratoire de Biologie de l'Exercice pour la Performance et la Santé, Université d'Evry, IRBA, Université Paris-Saclay, Evry, France.
  • Kremlin Bicêtre Medical School, Université Paris-Saclay, Kremlin Bicetre, France.

ORCID-Profile: Dured Dardari

Zitieren

APA

Dardari, D. (2026). When Glycaemic Control Comes Too Fast: Treatment‐Induced Neuropathy of Diabetes and Charcot Neuro‐Osteoarthropathy as Emerging Iatrogenic Complications of Rapid Metabolic Correction. Diabetes/Metabolism Research and Reviews, 42(6). https://doi.org/10.1002/dmrr.70210

Vancouver

Dardari D. When Glycaemic Control Comes Too Fast: Treatment‐Induced Neuropathy of Diabetes and Charcot Neuro‐Osteoarthropathy as Emerging Iatrogenic Complications of Rapid Metabolic Correction. Diabetes/Metabolism Research and Reviews. 2026;42(6). doi:10.1002/dmrr.70210

BibTeX
@article{Dardari2026,
  author = {Dardari, Dured},
  title = {When Glycaemic Control Comes Too Fast: Treatment‐Induced Neuropathy of Diabetes and Charcot Neuro‐Osteoarthropathy as Emerging Iatrogenic Complications of Rapid Metabolic Correction},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2026},
  volume = {42},
  number = {6},
  doi = {10.1002/dmrr.70210}
}
Kostenlos starten →